
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the second quarter, after the closing bell on Monday, Aug. 4.
Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.25 per share, versus a year-ago loss of $12.83 per share. Vertex Pharmaceuticals projects to report quarterly revenue at $2.91 billion, compared to $2.65 billion a year earlier, according to data from Benzinga Pro.